ISS Research Drives 3 U.S. Medical Programs Toward New Therapies as Station Funding Runs Through 2030
Updated
Updated · Aerospace America · May 21
ISS Research Drives 3 U.S. Medical Programs Toward New Therapies as Station Funding Runs Through 2030
1 articles · Updated · Aerospace America · May 21
Three U.S. medical centers—Cedars Sinai, Cleveland Clinic and the University of Pittsburgh—said ISS microgravity research is already shaping disease studies, treatment development and remote-health tools for use on Earth.
Cedars Sinai said its decade-old space medicine program used the first long-duration stem cell-derived heart muscle experiment in orbit to study heart function and advance space-based biomanufacturing of cell and gene therapies.
Cleveland Clinic said its Space Health Center, launched in April with more than 15 physician scientists, is adapting astronaut exercise therapy for POTS patients and building a space medicine course with ISS National Lab support.
University of Pittsburgh said Kate Rubins, who took over its space biomedicine institute in January, is translating astronaut physiology research into public-health applications, including tools suited for low-resource clinics such as those in Congo.
With the ISS funded through at least 2030, panelists said the field's next challenge is less proving microgravity science than building the infrastructure, standards and training needed to turn experiments into durable health platforms.
Beyond heart disease and aging, what other major terrestrial illnesses could be cured by research conducted in space?
With the ISS retiring after 2030, who is building the next generation of orbital labs for medical research?
How will revolutionary space-made medicines become affordable and accessible for everyday patients on Earth?
Microgravity Medicine in 2026: Tangible Advances from the ISS Transforming Cancer Treatment and Accelerating Therapies
Overview
Research on the International Space Station’s unique microgravity environment is leading to real improvements in patient care on Earth. By studying how gravity affects protein crystal growth, scientists developed a new subcutaneous injectable form of the cancer drug Keytruda. This innovation, made possible by improved drug formulations from space-based research, reduces treatment time from hours to just one minute. As a result, patients undergoing cancer therapy experience a much better quality of life. These advances show how discoveries in space can quickly translate into tangible health benefits for people on Earth.